Determinants of Anemia Occurrence in Cervix Ca Patients Undergoing Chemotherapy

Rosi Marlina; Siti Syaroha; Sukma Rahayu Pinanggih; Pungky Mulawardana; Budi Utomo

doi:10.37287/ijghr.v6iS4.4328

Rosi Marlina Universitas Airlangga
Siti Syaroha Universitas Airlangga
Sukma Rahayu Pinanggih Universitas Airlangga
Pungky Mulawardana Universitas Airlangga
Budi Utomo Universitas Airlangga

DOI: https://doi.org/10.37287/ijghr.v6iS4.4328

Keywords: anemia, cervical ca, chemotherapy, determinants

Abstract

Chemotherapy causes the death of some cells that have been formed from the process of DNA, RNA or protein synthesis. The myelosuppressive effects of long-term chemotherapy treatment will continue throughout the therapy cycle such as infection, septicemia and spontaneous bleeding and worsening of anemia. This study aims to determine the factors that influence the occurrence of anemia in cisplatin chemotherapy patients. This study used an analytical observational design with a retrospective cross-sectional approach (medical records). The population was 394 patients with a sample of 136 with a simple random sampling technique. Data were obtained from medical records and supporting examination results, then summarized and tabulated according to the coding. Data analysis used the chi square test. The results of this study obtained 86 patients who experienced anemia and as many as 136 cases of anemia with 35 patients experiencing recurrent anemia. The p value in the chi-square test for age with the occurrence of anemia was (p = 0.026), the p value in the chemotherapy series (p = 0.011), the p value in leukopenia with anemia (0.000), the p value in thrombocytosis (p = 0.004). The use of chemotherapy with cisplating has a significant relationship with anemia in patients with Ca Cervix IIIA - IVA. The use of chemotherapy with cisplatin has a significant relationship between age, leukopenia levels, thrombocytosis levels, and the series of chemotherapy used in the occurrence of anemia. So that chemotherapy can cause damage to the spinal cord, so that it fails to produce red blood cells, white blood cells, and platelets in the blood.

References

Annisa R. F. D and Merryana A., (2019) "Status Gizi, Asupan Energi dan Zat Gizi Makro Pasien Kanker yang Menjalani Kemoterapi di RUMKITAL Dr. Ramelan Surabaya, Amerta Nutrition", 3(3), pp. 149–157. doi: 10.2473/amnt.v3i3.2019.149-157.

Anggriani, B. et al. (2023) ‘Perempuan Dan Penyakit Keganasan (Kanker Payudara Dan Kanker Serviks)’, Electronic Journal Scientific of Environmental Health And Disease, 3(2), pp. 131–142. doi: 10.22437/esehad.v3i2.27654.

Audina, N. T., et al. (2019). "Nasofaring Yang Mendapatkan Kemoterapi Paclitaxel". Jurnal Kedokteran Diponegoro, 8(4), 1187–1196.

Bhatla, N. et al. (2018) "Cancer of the cervix uteri", International Journal of Gynecology and Obstetrics, 143, pp. 22–36. doi: 10.1002/ijgo.12611.

Bhavani, N. K. C. et al. (2020) "Penurunan kadar hemoglobin, leukosit dan trombosit pasca 3 seri kemoterapi pada kasus ca cervix di rumah sakit umum pusat sanglah denpasar bali kurun waktu 1 januari hingga 31 desember 2018", Jurnal Medika Udayana, 9(8), pp. 53–58. Available at: https://ocs.unud.ac.id/index.php/eum/article/view/69946/38214.

Dasari, S. and Bernard T. P., (2014) "Cisplatin in cancer therapy: Molecular mechanisms of action", European Journal of Pharmacology, 740, pp. 364–378. doi: 10.1016/j.ejphar.2014.07.025.

Dewi, T. Z., Nur, I. M. and Dananjaya, R. (2016) "Karakteristik Penderita Ca cervix Ditinjau Dari Usia , Paritas dan Gambaran Histopatologi di Bagian Patologi Anatomi Rumah Sakit Al Islam Bandung Periode 2012-2015 Characteristics of Cervical Cancer Patients In Terms of Age , Parity and Histopatholog", Prosiding Pendidikan Dokter, 2, pp. 337–342.

Dewi, N. M. A. P., Nurhesti, P. O. Y. and Damayanti, M. R. (2020) "Hubungan Antara Frekuensi Kemoterapi Dan Status Nutrisi Pasien Kanker Yang Menjalani Kemoterapi Di Ruang Sanjiwani Rsup Sanglah Denpasar", Coping: Community of Publishing in Nursing, 8(3), p. 258. doi: 10.24843/coping.2020.v08.i03.p06.

Febriani, A. and Rahmawati, Y. (2019) "Efek Samping Hematologi Akibat Kemoterapi dan Tatalaksananya", Jurnal Respirasi, 5(1), p. 22. doi: 10.20473/jr.v5-i.1.2019.22-28.

Ghosh, S. (2019) "Cisplatin: The first metal based anticancer drug", Bioorganic Chemistry. Academic Press Inc. doi: 10.1016/j.bioorg.2019.102925.

Hadi, S. and Iskandar, M. (2013) "Hubungan Anemia Dan Transfusi Darah Terhadap Respons Kemoradiasi Pada Karsinoma Cervix Uteri Stadium Iib - Iiib", Medica Hospitalia : Journal of Clinical Medicine, 1(1), pp. 32–36. doi: 10.36408/mhjcm.v1i1.37.

Iskandar, Z., et al. (2017). "Penurunan hemoglobin, neutrofil, dan trombosit pascakemoterapi cisplatin-paclitaxel pada penderita tumor ganas kepala dan leher". Jurnal THT-KL, 10(1), 1–10

Johanis, J., & Hajat, A. (2018). "Patogenesis Dan Pemeriksaan Laboratoprium Mielofibrosis Primer". Indonesian Journal of Clinical Pathology and Medical Laboratory, 17(2), 110. https://doi.org/10.24293/ijcpml.v17i2.1025

Kesehatan, F. I. (2017) "Program Studi S1 Farmasi Fakultas Ilmu Kesehatan", pp. 1–19.Kesehatan, K., Penanggulangan, K. and Nasional, K. (no date) ‘Ca cervix’.

Kusumawati, Dessy,., et al. (2017) "Hubungan Dukungan Keluarga Terhadap Keikutsertaan Ibu Dalam Deteksi Dini Ca Cervix Dengan Metode Inspeksi Visual Asam Asetat (Iva) Di Kelurahan Kedungmundu Kota Semarang" pp. 11–45.

Lasari, H., Amalia, M. and Sarmila (2021) ‘Upaya Promosi dan Pencegahan Kanker Payudara Menggunakan Whatsapp Messenger’, Higeia Journal of Public Health Research and Development, 5(2), pp. 227–238.

Lee, C. K., et al. (2021). "Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer". British Journal of Cancer, 105(3), 360–365. https://doi.org/10.1038/bjc.2011.256

Madeddu, C., et al. (2018). "Pathogenesis and treatment options of cancer related anemia: Perspective for a targeted mechanism-based approach". Frontiers in Physiology, 9(SEP), 1–20. https://doi.org/10.3389/fphys.2018.01294

Mersil, S. (2021). "Stomatitis sebagai Manifestasi Oral dari Anemia Defisiensi Zat Besi disertai Trombositosis". E-GiGi, 9(2), 181. https://doi.org/10.35790/eg.v9i2.34481

Morrison, J., et al. (2018). Epidermal growth factor receptor blockers for the treatment of ovarian cancer. Cochrane Database of Systematic Reviews, 2018(10). https://doi.org/10.1002/14651858.CD007927.pub4

Nirmawaty, D. A. (2007) "Deteksi Ca cervix (Carsinoma Cerviks Uteri) pada Citra Hasil Rekaman CT-Scan Menggunakan Jaringan Syaraf Tiruan Dewi", pp. 5–22.

Pangribowo, S. (2019) "Beban Kanker di Indonesia", pp. 1–16.

Sri Wahyuni, E. et al. (2022) ‘Pola Makan, Status Gizi, Asupan Gizi Dan Anemia Pada Pasien Kanker Yang Menjalani Kemoterapi’, Jurnal Kesehatan Masyarakat, 6(2), pp. 1864–1875.

Suwendar et al., (2016) "Evaluasi Outcome Klinik Regimen Kemoterapi Berbasis Cisplatin Terhadap Pasien Ca cervix", Prosiding Seminar Nasional Penelitian dan PKM Kesehatan, 6(I), pp. 13–18. Available at: http://proceeding.unisba.ac.id/index.php/kesehatan/article/view/1439k.

Stauder, R., et al. (2018). "Anemia at older age: etiologies, clinical implications, and management" Blood, 131(5), 505–514. https://doi.org/10.1182/blood-2017-07-746446

Suprayoga, D. (2021) "Pelatalaksanaan Keperawatan Kemoterapi", RS Paru Rotinsulu. Available at: http://web.rsparurotinsulu.org.

Utami, N. P. P. S. et al. (2020) "Karakteristik Pasien Ca cervix Di Rsup Sanglah Denpasar Periode 1 Januari – 31 Desember 2017", Jurnal Medika Udayana, 9(1), pp. 22–27.

Vera Novalia (2023) ‘Kanker Serviks ’, GALENICAL: Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh , 2(1), pp. 45–56.

Wassie, M.,et al. (2021) "Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia", BMC Women’s Health, 21(1), pp. 1–8. doi: 10.1186/s12905-021-01185-9.